GlassScriptPhysician profile
Stephen B Zimmer
NPI 1457424046
$2,956.11
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $782 · 2021: $1,395 · 2022: $24.23.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $440.64 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $269.70 | 2020-2021 | |
| Pfizer INC. | $228.13 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $197.31 | 2019-2021 | |
| Abbvie INC. | $174.43 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.25 | 2019-2021 | |
| Allergan, INC. | $131.07 | 2020 | |
| Daiichi Sankyo INC. | $117.58 | 2021 | |
| Janssen Pharmaceuticals, INC | $108.16 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $107.97 | 2020-2021 | |
| Lilly USA, LLC | $104.15 | 2019-2021 | |
| Esperion Therapeutics, INC. | $91.86 | 2021 | |
| Sanofi-Aventis U.S. LLC | $84.81 | 2019-2020 | |
| Eisai INC. | $84.77 | 2020-2021 | |
| Astellas Pharma US INC | $83.87 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $65.23 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $61.16 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $54.21 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $52.08 | 2019-2020 | |
| Genentech USA, INC. | $48.88 | 2019 | |
| Hikma Pharmaceuticals USA | $46.91 | 2019-2021 | |
| Amgen INC. | $45.05 | 2019-2020 | |
| Philips North America LLC | $34.46 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.49 | 2021 | |
| Dexcom, INC. | $27.29 | 2021 | |
| Nestle Healthcare Nutrition INC. | $25.45 | 2021 | |
| Amarin Pharma, INC. | $19.62 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $14.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.22 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.91 | 2019 | |
| Merck Sharp & Dohme LLC | $11.67 | 2019 | |
| Zyla Life Sciences, INC. | $11.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Zimmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.